Share Price and Basic Stock Data
Last Updated: December 11, 2025, 9:56 pm
| PEG Ratio | -48.87 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uravi Defence & Technology Ltd operates in the niche auto ancillary sector, focusing on equipment lamps. The company’s recent performance has shown some fluctuations in sales, with reported revenues of ₹43.63 Cr for FY 2025, slightly declining from the trailing twelve months (TTM) figure of ₹42.56 Cr. In the most recent quarter ending June 2025, sales stood at ₹10.02 Cr, reflecting a dip from ₹11.40 Cr in March 2025. This inconsistency in revenue generation raises some eyebrows, especially considering the overall market dynamics. The company’s operating profit margin (OPM) for the same quarter was recorded at 12.18%, suggesting that while the revenue generation is not robust, the company manages to maintain a decent margin amidst varying sales levels. With a cash conversion cycle (CCC) of 511.92 days, the operational efficiency appears to be stretched, indicating potential delays in cash flow management which could affect short-term liquidity.
Profitability and Efficiency Metrics
Uravi’s profitability metrics present a mixed picture. The net profit for FY 2025 was reported at ₹2.55 Cr, yielding an earnings per share (EPS) of ₹2.18. While the company maintains a reasonable net profit margin of 4.46%, the price-to-earnings (P/E) ratio stands at a staggering 92.9. Such a high P/E might suggest that the market has high expectations for future growth, but it also raises concerns about valuation. The interest coverage ratio (ICR) of 3.54x indicates that the company is comfortably managing its interest obligations, which is a positive sign in terms of financial health. However, the operational efficiency metrics, particularly the debtor days at 119.97 and inventory days at 453.33, suggest that the company may be facing challenges in converting sales into cash. This scenario could lead to liquidity issues if not managed effectively, particularly in fluctuating market conditions.
Balance Sheet Strength and Financial Ratios
The balance sheet of Uravi Defence reveals a mixed financial health profile. The company has reported total borrowings of ₹25.71 Cr against reserves of ₹38.98 Cr, which reflects a manageable debt situation with a debt-to-equity ratio of 0.48. This indicates that the firm is not heavily leveraged, which is a strength in times of economic uncertainty. However, the book value per share stands at ₹46.91, while the share price is ₹168, translating to a price-to-book value (P/BV) ratio of 7.47x. This ratio suggests that the stock may be overvalued, particularly in light of the modest return on equity (ROE) of 4.81%. Furthermore, the company’s liquidity ratios, with a current ratio of 1.90 and a quick ratio of 1.11, indicate that it is in a comfortable position to meet its short-term liabilities. However, the significant cash conversion cycle could pose issues for operational liquidity.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uravi Defence provides insights into investor sentiment and confidence. As of September 2025, promoters hold 58.39% of the company, a significant reduction from 72.73% in December 2022. This decline in promoter holding may raise questions about their confidence in the company’s future. In contrast, foreign institutional investors (FIIs) have increased their stake to 8.24%, which could indicate growing interest from external investors. The public shareholding has also seen an increase to 33.38%, suggesting that retail investor interest is on the rise, which is a positive sign. The number of shareholders has surged to 3,133, up from just 236 in December 2022, reflecting a growing retail participation. However, the declining promoter stake may signal potential risks which investors should monitor closely, as it could affect governance and strategic decision-making.
Outlook, Risks, and Final Insight
Looking ahead, Uravi Defence & Technology faces a mixed outlook. On one hand, the increasing interest from FIIs and the rise in public shareholding suggest a positive trend in investor confidence. On the other hand, the company’s high P/E ratio, coupled with a stretched cash conversion cycle and fluctuating revenue, raises concerns about sustainability and operational efficiency. Investors may want to keep an eye on how effectively the management can enhance cash flow and improve sales consistency. Risks such as potential liquidity issues due to the lengthy cash conversion cycle and the declining promoter stake could pose challenges. Therefore, while the stock may attract interest for its growth potential, investors should proceed cautiously, weighing the strengths against the risks as they consider their investment strategy in the evolving landscape of the auto ancillary sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Uravi Defence & Technology Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Varroc Engineering Ltd | 9,856 Cr. | 647 | 695/365 | 50.9 | 110 | 0.15 % | 17.1 % | 7.37 % | 1.00 |
| Uravi Defence & Technology Ltd | 186 Cr. | 163 | 588/153 | 90.5 | 44.2 | 0.00 % | % | % | 10.0 |
| Lumax Industries Ltd | 5,220 Cr. | 5,590 | 5,870/1,960 | 35.0 | 873 | 0.63 % | 16.4 % | 19.3 % | 10.0 |
| Fiem Industries Ltd | 5,987 Cr. | 2,273 | 2,378/1,156 | 26.7 | 410 | 1.32 % | 27.8 % | 21.0 % | 10.0 |
| Industry Average | 5,312.25 Cr | 2,168.25 | 50.78 | 359.30 | 0.53% | 20.43% | 15.89% | 7.75 |
Quarterly Result
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|
| Sales | 11.12 | 10.02 | 11.40 | 10.02 |
| Expenses | 9.62 | 9.08 | 9.65 | 8.80 |
| Operating Profit | 1.50 | 0.94 | 1.75 | 1.22 |
| OPM % | 13.49% | 9.38% | 15.35% | 12.18% |
| Other Income | 0.07 | 0.37 | 0.33 | 0.40 |
| Interest | 0.57 | 0.40 | 0.39 | 0.39 |
| Depreciation | 0.55 | 0.55 | 0.51 | 0.52 |
| Profit before tax | 0.45 | 0.36 | 1.18 | 0.71 |
| Tax % | 33.33% | 25.00% | 31.36% | 25.35% |
| Net Profit | 0.35 | 0.71 | 0.93 | 0.53 |
| EPS in Rs | 0.32 | 0.65 | 0.76 | 0.39 |
Last Updated: August 20, 2025, 1:45 am
Below is a detailed analysis of the quarterly data for Uravi Defence & Technology Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 10.02 Cr.. The value appears to be declining and may need further review. It has decreased from 11.40 Cr. (Mar 2025) to 10.02 Cr., marking a decrease of 1.38 Cr..
- For Expenses, as of Jun 2025, the value is 8.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.65 Cr. (Mar 2025) to 8.80 Cr., marking a decrease of 0.85 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.22 Cr.. The value appears to be declining and may need further review. It has decreased from 1.75 Cr. (Mar 2025) to 1.22 Cr., marking a decrease of 0.53 Cr..
- For OPM %, as of Jun 2025, the value is 12.18%. The value appears to be declining and may need further review. It has decreased from 15.35% (Mar 2025) to 12.18%, marking a decrease of 3.17%.
- For Other Income, as of Jun 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from 0.33 Cr. (Mar 2025) to 0.40 Cr., marking an increase of 0.07 Cr..
- For Interest, as of Jun 2025, the value is 0.39 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.39 Cr..
- For Depreciation, as of Jun 2025, the value is 0.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.51 Cr. (Mar 2025) to 0.52 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.71 Cr.. The value appears to be declining and may need further review. It has decreased from 1.18 Cr. (Mar 2025) to 0.71 Cr., marking a decrease of 0.47 Cr..
- For Tax %, as of Jun 2025, the value is 25.35%. The value appears to be improving (decreasing) as expected. It has decreased from 31.36% (Mar 2025) to 25.35%, marking a decrease of 6.01%.
- For Net Profit, as of Jun 2025, the value is 0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 0.93 Cr. (Mar 2025) to 0.53 Cr., marking a decrease of 0.40 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.39. The value appears to be declining and may need further review. It has decreased from 0.76 (Mar 2025) to 0.39, marking a decrease of 0.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:12 am
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 43.63 | 42.56 |
| Expenses | 37.85 | 37.15 |
| Operating Profit | 5.78 | 5.41 |
| OPM % | 13.25% | 12.71% |
| Other Income | 0.97 | 1.17 |
| Interest | 1.91 | 1.75 |
| Depreciation | 2.05 | 2.13 |
| Profit before tax | 2.79 | 2.70 |
| Tax % | 30.11% | |
| Net Profit | 2.55 | 2.52 |
| EPS in Rs | 2.18 | 2.10 |
| Dividend Payout % | 0.00% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 49% |
| 3 Years: | 44% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:10 am
| Month | Mar 2025 | Sep 2025 |
|---|---|---|
| Equity Capital | 11.26 | 11.36 |
| Reserves | 35.10 | 38.98 |
| Borrowings | 25.88 | 25.71 |
| Other Liabilities | 16.53 | 14.08 |
| Total Liabilities | 88.77 | 90.13 |
| Fixed Assets | 19.58 | 19.26 |
| CWIP | 2.71 | 2.78 |
| Investments | 0.19 | 8.98 |
| Other Assets | 66.29 | 59.11 |
| Total Assets | 88.77 | 90.13 |
Below is a detailed analysis of the balance sheet data for Uravi Defence & Technology Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.36 Cr.. The value appears strong and on an upward trend. It has increased from 11.26 Cr. (Mar 2025) to 11.36 Cr., marking an increase of 0.10 Cr..
- For Reserves, as of Sep 2025, the value is 38.98 Cr.. The value appears strong and on an upward trend. It has increased from 35.10 Cr. (Mar 2025) to 38.98 Cr., marking an increase of 3.88 Cr..
- For Borrowings, as of Sep 2025, the value is 25.71 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 25.88 Cr. (Mar 2025) to 25.71 Cr., marking a decrease of 0.17 Cr..
- For Other Liabilities, as of Sep 2025, the value is 14.08 Cr.. The value appears to be improving (decreasing). It has decreased from 16.53 Cr. (Mar 2025) to 14.08 Cr., marking a decrease of 2.45 Cr..
- For Total Liabilities, as of Sep 2025, the value is 90.13 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 88.77 Cr. (Mar 2025) to 90.13 Cr., marking an increase of 1.36 Cr..
- For Fixed Assets, as of Sep 2025, the value is 19.26 Cr.. The value appears to be declining and may need further review. It has decreased from 19.58 Cr. (Mar 2025) to 19.26 Cr., marking a decrease of 0.32 Cr..
- For CWIP, as of Sep 2025, the value is 2.78 Cr.. The value appears strong and on an upward trend. It has increased from 2.71 Cr. (Mar 2025) to 2.78 Cr., marking an increase of 0.07 Cr..
- For Investments, as of Sep 2025, the value is 8.98 Cr.. The value appears strong and on an upward trend. It has increased from 0.19 Cr. (Mar 2025) to 8.98 Cr., marking an increase of 8.79 Cr..
- For Other Assets, as of Sep 2025, the value is 59.11 Cr.. The value appears to be declining and may need further review. It has decreased from 66.29 Cr. (Mar 2025) to 59.11 Cr., marking a decrease of 7.18 Cr..
- For Total Assets, as of Sep 2025, the value is 90.13 Cr.. The value appears strong and on an upward trend. It has increased from 88.77 Cr. (Mar 2025) to 90.13 Cr., marking an increase of 1.36 Cr..
Notably, the Reserves (38.98 Cr.) exceed the Borrowings (25.71 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2025 |
|---|---|
| Free Cash Flow | -20.10 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2025 |
|---|---|
| Debtor Days | 119.97 |
| Inventory Days | 453.33 |
| Days Payable | 61.37 |
| Cash Conversion Cycle | 511.92 |
| Working Capital Days | 122.81 |
| ROCE % |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 2.31 |
| Diluted EPS (Rs.) | 2.25 |
| Cash EPS (Rs.) | 3.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.91 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.91 |
| Revenue From Operations / Share (Rs.) | 38.75 |
| PBDIT / Share (Rs.) | 5.99 |
| PBIT / Share (Rs.) | 4.17 |
| PBT / Share (Rs.) | 2.48 |
| Net Profit / Share (Rs.) | 1.73 |
| NP After MI And SOA / Share (Rs.) | 2.26 |
| PBDIT Margin (%) | 15.46 |
| PBIT Margin (%) | 10.76 |
| PBT Margin (%) | 6.39 |
| Net Profit Margin (%) | 4.46 |
| NP After MI And SOA Margin (%) | 5.83 |
| Return on Networth / Equity (%) | 4.81 |
| Return on Capital Employeed (%) | 8.54 |
| Return On Assets (%) | 2.86 |
| Long Term Debt / Equity (X) | 0.02 |
| Total Debt / Equity (X) | 0.48 |
| Current Ratio (X) | 1.90 |
| Quick Ratio (X) | 1.11 |
| Interest Coverage Ratio (X) | 3.54 |
| Interest Coverage Ratio (Post Tax) (X) | 2.02 |
| Enterprise Value (Cr.) | 404.69 |
| EV / Net Operating Revenue (X) | 9.28 |
| EV / EBITDA (X) | 59.98 |
| MarketCap / Net Operating Revenue (X) | 9.05 |
| Price / BV (X) | 7.47 |
| Price / Net Operating Revenue (X) | 9.05 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Uravi Defence & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.55. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.91. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.91. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 38.75. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.99. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.17. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.48. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.26. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 15.46. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 10.76. This value is within the healthy range. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 6.39. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 4.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.83. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.81. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.54. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 2.86. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.11. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.54. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 404.69. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.28. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 59.98. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 7.47. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uravi Defence & Technology Ltd:
- Net Profit Margin: 4.46%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.54% (Industry Average ROCE: 15.33%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.81% (Industry Average ROE: 11.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.02
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.11
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 90.5 (Industry average Stock P/E: 50.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.46%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Equipment Lamp | Shop No. 329 Avior, Nirmal Galaxy, Mumbai Maharashtra 400080 | info@uravilamps.com http://www.uravilamps.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Niraj Damji Gada | Managing Director & CEO |
| Mr. Kaushik Damji Gada | WholeTime Director & CFO |
| Mr. Brijesh Aggarwal | Non Executive Director |
| Ms. Shreya Ramkrishnan | Ind. Non-Executive Director |
| Mr. Sreedhar Ramachandran Ayalur | Ind. Non-Executive Director |
| Mr. Niken Shah | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Uravi Defence & Technology Ltd?
Uravi Defence & Technology Ltd's intrinsic value (as of 11 December 2025) is 489.61 which is 200.37% higher the current market price of 163.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 186 Cr. market cap, FY2025-2026 high/low of 588/153, reserves of ₹38.98 Cr, and liabilities of 90.13 Cr.
What is the Market Cap of Uravi Defence & Technology Ltd?
The Market Cap of Uravi Defence & Technology Ltd is 186 Cr..
What is the current Stock Price of Uravi Defence & Technology Ltd as on 11 December 2025?
The current stock price of Uravi Defence & Technology Ltd as on 11 December 2025 is 163.
What is the High / Low of Uravi Defence & Technology Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uravi Defence & Technology Ltd stocks is 588/153.
What is the Stock P/E of Uravi Defence & Technology Ltd?
The Stock P/E of Uravi Defence & Technology Ltd is 90.5.
What is the Book Value of Uravi Defence & Technology Ltd?
The Book Value of Uravi Defence & Technology Ltd is 44.2.
What is the Dividend Yield of Uravi Defence & Technology Ltd?
The Dividend Yield of Uravi Defence & Technology Ltd is 0.00 %.
What is the ROCE of Uravi Defence & Technology Ltd?
The ROCE of Uravi Defence & Technology Ltd is %.
What is the ROE of Uravi Defence & Technology Ltd?
The ROE of Uravi Defence & Technology Ltd is %.
What is the Face Value of Uravi Defence & Technology Ltd?
The Face Value of Uravi Defence & Technology Ltd is 10.0.